Literature DB >> 23206854

Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.

Michael Rink1, Emily C Zabor, Helena Furberg, Evanguelos Xylinas, Behfar Ehdaie, Giacomo Novara, Marko Babjuk, Armin Pycha, Yair Lotan, Quoc-Dien Trinh, Felix K Chun, Richard K Lee, Pierre I Karakiewicz, Margit Fisch, Brian D Robinson, Douglas S Scherr, Shahrokh F Shariat.   

Abstract

BACKGROUND: Cigarette smoking is the best-established risk factor for urothelial carcinoma development.
OBJECTIVE: To elucidate the association of pretreatment smoking status, cumulative exposure, and time since smoking cessation on outcomes of patients with urothelial carcinoma of the bladder (UCB) treated with radical cystectomy (RC). DESIGN, SETTING, AND PARTICIPANTS: We retrospectively collected clinicopathologic and smoking variables, including smoking status, number of cigarettes per day (CPD), duration in years, and time since smoking cessation, for 1506 patients treated with RC for UCB. Lifetime cumulative smoking exposure was categorized as light short-term (≤20 CPD for ≤20 yr), light long-term (≤20 CPD for >20 yr), heavy short-term (>20 CPD for ≤20 yr), and heavy long-term (>20 CPD for >20 yr). INTERVENTION: RC and bilateral lymph node (LN) dissection without neoadjuvant chemotherapy. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Logistic regression and competing risk analyses assessed the association of smoking with disease recurrence, cancer-specific mortality, and overall mortality. RESULTS AND LIMITATIONS: There was no difference in clinicopathologic factors between patients who had never smoked (20%), former smokers (46%), and current smokers (34%). Smoking status was associated with the cumulative incidence of disease recurrence (p=0.004) and cancer-specific mortality (p=0.016) in univariable analyses and with disease recurrence in multivariable analysis (p=0.02); current smokers had the highest cumulative incidences. Among ever smokers, cumulative smoking exposure was associated with advanced tumor stages (p<0.001), LN metastasis (p=0.002), disease recurrence (p<0.001), cancer-specific mortality (p=0.001), and overall mortality (p=0.037) in multivariable analyses that adjusted for standard characteristics; heavy long-term smokers had the worst outcomes, followed by light long-term, heavy short-term, and light short-term smokers. Smoking cessation ≥10 yr mitigated the risk of disease recurrence (hazard ratio [HR]: 0.44; p<0.001), cancer-specific mortality (HR: 0.42; p<0.001), and overall mortality (HR: 0.69; p=0.012) in multivariable analyses. The study is limited by its retrospective nature.
CONCLUSIONS: Smoking is associated with worse prognosis after RC for UCB. This association seems to be dose-dependent, and its effects are mitigated by >10 yr smoking cessation. Health care practitioners should counsel smokers regarding the detrimental effects of smoking and the benefits of smoking cessation on UCB etiology and prognosis.
Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dose response; Muscle-invasive bladder cancer; Progression; Radical cystectomy; Recurrence; Smoking; Survival; Urothelial carcinoma

Mesh:

Year:  2012        PMID: 23206854     DOI: 10.1016/j.eururo.2012.11.039

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  25 in total

1.  Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.

Authors:  Harun Fajkovic; Shahrokh F Shariat; Tobias Klatte; Mihai Dorin Vartolomei; Ilaria Lucca; Aurélie Mbeutcha; Morgan Rouprêt; Alberto Briganti; Pierre I Karakiewicz; Vitaly Margulis; Michael Rink; Mesut Remzi; Christian Seitz; Karim Bensalah; Romain Mathieu
Journal:  World J Urol       Date:  2016-02-15       Impact factor: 4.226

2.  Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.

Authors:  Yohann Dabi; Yohann Rouscoff; Julien Anract; Nicolas Barry Delongchamps; Mathilde Sibony; Djillali Saighi; Marc Zerbib; Michael Peyraumore; Evanguelos Xylinas
Journal:  World J Urol       Date:  2016-06-06       Impact factor: 4.226

Review 3.  Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer.

Authors:  Marianne Schmid; Shahrokh F Shariat; Armin Soave; Oliver Engel; Margit Fisch; Michael Rink
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

Review 4.  Enhanced recovery protocols (ERP) in robotic cystectomy surgery. Review of current status and trends.

Authors:  Christofer Adding; Justin W Collins; Oscar Laurin; Abolfazl Hosseini; N Peter Wiklund
Journal:  Curr Urol Rep       Date:  2015-05       Impact factor: 3.092

5.  Exercise Decreases and Smoking Increases Bladder Cancer Mortality.

Authors:  Michael A Liss; Martha White; Loki Natarajan; J Kellogg Parsons
Journal:  Clin Genitourin Cancer       Date:  2016-12-01       Impact factor: 2.872

6.  Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis.

Authors:  Beat Foerster; Carmen Pozo; Mohammad Abufaraj; Andrea Mari; Shoji Kimura; David D'Andrea; Hubert John; Shahrokh F Shariat
Journal:  JAMA Oncol       Date:  2018-07-01       Impact factor: 31.777

7.  Smoking status, usual adult occupation, and risk of recurrent urothelial bladder carcinoma: data from The Cancer Genome Atlas (TCGA) Project.

Authors:  Amber N Wilcox; Debra T Silverman; Melissa C Friesen; Sarah J Locke; Daniel E Russ; Noorie Hyun; Joanne S Colt; Jonine D Figueroa; Nathaniel Rothman; Lee E Moore; Stella Koutros
Journal:  Cancer Causes Control       Date:  2016-11-01       Impact factor: 2.506

8.  Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?

Authors:  Seung Hee Choi; Jeffrey E Terrell; Carol R Bradford; Tamer Ghanem; Matthew E Spector; Gregory T Wolf; Isaac M Lipkus; Sonia A Duffy
Journal:  Nicotine Tob Res       Date:  2016-08-18       Impact factor: 4.244

9.  Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants.

Authors:  Maria C Mir; Andrew J Stephenson; Robert L Grubb; Amanda Black; Adam S Kibel; Grant Izmirlian
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-02       Impact factor: 4.254

10.  Morbidity, mortality, and quality assessment following open radical cystectomy in elderly patients with bladder cancer.

Authors:  Tommaso Prayer Galetti; Matteo Soligo; Alessandro Morlacco; Valeria Lami; Alex Anh Ly Nguyen; Massimo Iafrate; Filiberto Zattoni
Journal:  Aging Clin Exp Res       Date:  2020-06-13       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.